Yuji Soejima, Akinobu Taketomi, Tomoharu Yoshizumi, Hideaki Uchiyama, Noboru Harada, Hideki Ijichi, Yusuke Yonemura, Tetsuo Ikeda, Mitsuo Shimada, Yoshihiko Maehara – 23 May 2006 – Biliary complications, biliary strictures (BS) in particular, continue to be a significant cause of morbidity after LDLT despite technical refinement. In this study, we assessed the incidence of BS and their management in living donor liver transplantation (LDLT) with special reference to the type of biliary reconstruction.

23 May 2006

Yasutsugu Takada, Mikiko Ueda, Takashi Ito, Seisuke Sakamoto, Hironori Haga, Yoji Maetani, Kohei Ogawa, Mureo Kasahara, Fumitaka Oike, Hiroto Egawa, Koichi Tanaka – 23 May 2006 – Living donor liver transplantation (LDLT) has evolved to represent an important surgical strategy for patients with hepatocellular carcinoma (HCC). However, due to disadvantages, including donor risks and higher rates of perioperative complications, LDLT has been considered as a second‐line treatment in Japan.

Ashok Jain, Ravi Mohanka, Mark Orloff, Peter Abt, Charlotte Ryan, Adel Bozorgzadeh – 23 May 2006

Shin Hwang, Sung‐Gyu Lee, Young‐Joo Lee, Kyu‐Bo Sung, Kwang‐Min Park, Ki‐Hun Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Gyu‐Sam Hwang, Kyung‐Mo Kim, Tae‐Yong Ha, Dong‐Sik Kim, Jae‐Pil Jung, Gi‐Won Song – 23 May 2006 – Serious complications have occurred in a considerable proportion of living donors of liver transplants, but data from a single high‐volume center has rarely been available. We analyzed the medical records of donors and recipients of the first 1,000 living donor liver transplants, performed at Asan Medical Center from December 1994 to June 2005, with a focus on donor safety.

Muslim Atiq, Guy W. Neff, Christos Argyropoulos, Mark Schroer, Nyingi Kemmer, Fredrick Weber, Joseph Buell – 23 May 2006

Pietro Majno, Vincenzo Mazzaferro – 23 May 2006

James D. Perkins – 23 May 2006

Jean F. Botha, Wendy J. Grant, Clarivet Torres, Angie K. Iverson, Debra L. Sudan, Byers W. Shaw, Alan N. Langnas – 18 May 2006 – Infants with short bowel syndrome (SBS) and associated liver failure are often referred for combined liver/intestinal transplantation. We speculated that in some young children, nutritional autonomy would be possible with restoration of normal liver function. Features we believed to predict nutritional autonomy include history of at least 50% enteral tolerance, age less than 2 yr, and no underlying intestinal disease.

Giorgio Ercolani, Gian Luca Grazi, Matteo Ravaioli, Massimo Del Gaudio, Matteo Cescon, Giovanni Varotti, Giovanni Ramacciato, Gaetano Vetrone, Matteo Zanello, Antonio Daniele Pinna – 18 May 2006 – Impact of hepatitis C virus (HCV) recurrence on long‐term outcome after orthotopic liver transplantation (OLT) is highly variable, and the role of retransplantation is still debated. From 1996 to 2003, 131 OLT with histologically proven HCV recurrence and 6 months of follow‐up were retrospectively reviewed. One and 5‐yr overall survivals were 90.7 and 81.3%, respectively.